Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many proteins in biology exist in more than one form. Examples include ion channels that control electrical activity in the body, metabolic enzymes, and proteins called transcription factors that help control gene expression. In immune cells, one family of transcription factors, the NFAT family, is important in cell differentiation and activation. NFATs control the expression of genes that produce signaling molecules that help co-ordinate the activities of different immune cells and defective NFAT activation is linked to a range of human diseases. Immune cells express several different NFATs, and it has proved difficult to control selectively the activity of each protein.

Professor Anant Parekh’s group in DPAG have discovered how different NFAT proteins are controlled in cells. Their new findings, published in this month’s Molecular Cell (58, 232-243), demonstrate that different patterns of signal recruit different NFAT proteins. Their results open up the possibility for drugs aimed at targeting one NFAT protein and not another, allowing for selective therapeutic control of an immune response.

Read more (Department of Physiology, Anatomy and Genetics website)

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

No benefit of convalescent plasma for critically ill COVID-19 patients

A large study of over 2000 COVID-19 patients has found that giving critically ill patients blood plasma from recovered COVID-19 patients did not significantly reduce deaths, or the need for intensive care support such as being put on a ventilator machine.